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Abstract.  Collagen XIV was isolated from neutral salt 
extracts of human placenta and purified by several 
chromatographic steps including affinity binding to 
heparin. The same procedures also led to the 
purification of a tissue form of fibronectin. Collagen 
XIV was demonstrated by partial sequence analysis of 
its Coil and Co12 domains and by electron microscopy 
to be a disulphide-linked molecule with a characteris- 
tic cross-shape.  The individual chains had a size of 
'~210 kD,  which was reduced to ~180 kD (domain 
NC3) after treatment with bacterial collagenase. 
Specific  antibodies mainly to NC3 epitopes were ob- 
tained by affinity chromatography and used in tissue 
and cell analyses by immunoblotting and radioim- 
munoassays. Two sequences from NC3  were identified 
on fragments obtained after trypsin cleavage.  They 
were identical to cDNA-derived sequences of undulin, 
a noncollagenous extracellular matrix protein. This 
suggests  that collagen XIV and undulin may be differ- 
ent splice variants from the same gene. Heparin bind- 
ing was confirmed in ligand assays with a large base- 
ment membrane heparan sulphate proteoglycan. This 
binding could be inhibited by heparin and heparan sul- 
phate but not by chondroitin sulphate.  In addition, col- 
lagen XIV bound to the triple helical domain of colla- 
gen VI. The interactions with heparan sulphate 
proteoglycan and collagen VI were not shared by the 
NC3 domain, or by reduced and alkylated collagen 
XIV. No or only low binding was observed for colla- 
gens I-V, pN-collagens I and III, and several  noncol- 
lagenous matrix proteins, including laminin, recom- 
binant nidogen, BM-40/osteonectin, plasma and tissue 
fibronectin, vitronectin, and von Willebrand factor. In- 
significant activity was also shown in cell attachment 
assays with nine established cell lines. 
C 
OLLAGENS represent  a large family of extracellular 
matrix proteins  that share as a common  structural 
element a triple helical domain composed of three 
polypeptide chains with repeating Gly-Xaa-Yaa sequences. 
So far 14 different collagens, referred to as types I-XIV, and 
more  than  20  corresponding  genes  have been  identified 
(Vuorio and de Crombrugghe,  1990; van der Rest and Gar- 
rone, 1991). The collagens differ in their biological functions 
and  can  be  divided  into  major  classes  based  on  their 
supramolecular organization into large fibrils (types I-III, V, 
XI), microfibrils (type VI), networks (types IV, VIII), and an- 
choring fibrils (type VII). A special class of fibril-associated 
collagens with interrupted triple helices (FACITs)  ~  has been 
proposed, including the types IX, XII, and XIV, which show 
limited sequence homology and apparently do not self as- 
semble into large structures (Shaw and Olsen, 1991; van der 
Rest et al.,  1991). Fibril  association has so far only been 
demonstrated for collagen IX, which binds to the surface of 
collagen type II fibrils in cartilage  (Vaughan et al.,  1988; 
Eyre et al.,  1987; van der Rest and Mayne,  1988). 
1.  Abbreviations  used  in  this  paper:  EHS,  Engelbreth-Holm-Swarm; 
FACITs, fibril-associated collagens with interrupted triple helices. 
Collagen IX consists of three different ct chains, cd(IX), 
ot2(IX), and a3(IX),  which  are  connected  by disulphide 
bridges.  They fold into three relatively short triple helical 
domains  (Coil  to  Co13), separated  by  small  nonhelical 
regions and a globular domain NC4 (~30 kD) present at the 
NH2 terminus of the cd(IX) chain (Shaw and Olsen,  1991; 
van der Rest et al., 1991). Domains homologous to Coil and 
NC4 but not to Co12 and Co13 have also been detected in col- 
lagen XII (Gordon et al.,  1987, 1989; Dublet and van der 
Rest, 1987), which is found in several noncartilagenous ma- 
trices (Sugrue et al., 1989). Its NH2-terminal nontriple he- 
lical domain NC3 is quite large (~200 kD) and after rotary 
shadowing shows a three-armed structure that is connected 
to a short triple helix (Dublet et al., 1989). A 3,100-residue 
sequence based on cDNA clones has recently been reported 
for the cd(XII) chain of chick collagen XII (Yamagata et al., 
1991). This demonstrates a modular structure for NC3 with 
18 fibronectin type III motifs, four von Willebrand factor do- 
main A motifs, and a domain similar to the cd(IX) domain 
NC4.  Some  evidence  for  alternative  splicing  was  also 
provided that could explain why the size of NC3 isolated so 
far from tissues is distinctly smaller than predicted from the 
entire sequence (Yamagata et al.,  1991). 
Two type XII-like collagens were recently separated from 
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mains (Lunstrum et al., 1991a). This, together with different 
immunogold localizations (Keene et al., 1991), indicates that 
several  proteins  with  homologous  structures  may  exist. 
Similar  three-armed  structures  had  in  fact  already  been 
shown to be present in collagen VII (Lunstrum et al., 1986) 
and in the noncoUagenous matrix protein undulin (Schuppan 
et al.,  1990). Evidence for a novel collagen XIV was then 
obtained by sequencing a new Coil domain from fetal bovine 
tendons (Dublet and van der Rest,  1991) and  from chick 
cDNA (Gordon et al.,  1991) that was homologous to Coil 
of ~xl(IX) and cd(XII) chains. More recently, a cDNA encod- 
ing a long stretch of the chick collagen XIV NC3 domain and 
part of the Co12  domain has been sequenced (Trueb and 
Trueb,  1992).  The structural data for Coll also shows that 
both collagen XII and XIV are likely to consist of three iden- 
tical ot chains. Native collagen XIV, however, has so far not 
been characterized, nor is its entire sequence known. 
Whether collagens XII and XIV are in fact bound to the 
surface of collagen fibrils is still unknown, and the immuno- 
logical evidence for this is rather circumstantial (Sugrue et 
al.,  1989;  Keene  et  al.,  1991).  Here,  we  describe  the 
purification of collagen  XIV  from human  placenta  using 
neutral salt extraction as used before for the isolation of lami- 
nin isoforms (Brown et al.,  1990).  The identity of the ex- 
tracted protein with collagen XIV was demonstrated by par- 
tial sequence analyses, electron microscopy, and proteolytic 
fragmentation.  Collagen  XIV  showed  distinct  binding  to 
heparin and heparan sulphate proteoglycan and to collagen 
VI but not to various fibril-forming collagens and several 
other extracellular matrix proteins. This defines new func- 
tions for collagen XIV and raises the question as to whether 
different FACITs do in fact have similar biological roles. 
Materials and Methods 
Purification of Collagen XIV and Fibronectin from 
Human Placenta 
Fresh placentae were washed, homogenized, and extracted as previously 
described for the preparation of human laminin (Brown et al., 1990) except 
that the extraction buffer consisted of 20 mM Tris-HC1,  10 mM EDTA, 1 M 
NaCI, 10 mM sodium azide, 0.3 mM PMSE 10 mM N-ethylmaleimide, pH 
7.4,  with no Triton X-100. Two 5 M NaCI precipitations were carried out 
as before (Brown et al., 1990). The second NaC1 precipitate was redissolved 
in extraction buffer and dialyzed against the same buffer containing 0.1 M 
NaCI  and  without N-ethylmaleimide.  The  material  was  passed over  a 
heparin-Sepharose column (80 ml), and bound material was eluted with a 
0.1-0.5 M NaCI gradient (600 ml), Eluted fractions were analyzed by elec- 
trophoresis,  and  those containing collagen XIV  were  pooled~  dialyzed 
against 50 mM Tris-HCl, 10 mM EDTA, 0.1 M NaC1, pH 8.0, then passed 
over an  FPLC  MonoQ column (HR5/5;  Pharmacia Biosystems GmbH, 
Freiburg, Germany) equilibrated in the same buffer.  Bound proteins were 
eluted with a 0.1-0.6  M NaCI gradient (30 ml). The peak eluting at "~0.4 
M  NaCI  was concentrated and size fractionated by FPLC on Superose 6 
(100 ml; Pharmacia LKB Biotechnology, Inc.) equilibrated with 0.2 M am- 
monium hydrogen carbonate. The first eluted peak, which contained colla- 
gen XIV, was pooled and stored at  -20~ 
Reduction and alkylation of collagen XIV was carried out in 6 M guani- 
dine. HCI, 0.1 M Tris-HC1,  pH 6.9 with 0.02 M dithiothreitol (5 h, 37~ 
The reaction was stopped by adding a  fourfold molar excess of N-ethyl- 
maleimide (2.5  h,  37~  followed by dialysis against 0.2 M  ammonium 
hydrogen carbonate. 
The  fibronectin, which eluted  with collagen XIV  from the heparin- 
Sepharose column, was separated from it on the MonoQ column, where it 
eluted at 0.25-0.3 M NaC1. This material was dialyzed against 0.2 M am- 
monium hydrogen carbonate and stored at  -20~ 
Sources of Other Proteins and of Glycosaminoglycans 
A large heparan sulphate proteoglycan of low buoyant density was purified 
from the mouse Engelbreth-Holm-Swarm (EHS) tumor as described (Pauls- 
son et al., 1987a). The same tumor was used to purify the laminin-nidogen 
complex (Paulsson et al., 1987b).  Human laminin was isolated from placen- 
tal extracts by procedures similar to those used previously (Brown et al., 
1990).  It was shown (Brown et al., unpublished) to consist of two isoforms 
of laminin with the chain compositions BleAmB2e and BlsAmB2e, respec- 
tively  (for  nomenclature,  see  Engel  et  al.,  1991). Plasma  fibronectin 
(Behringwerke AG, Marburg, Germany) was further purified on heparin- 
Sepharose (see above). Recombinant mouse nidogen (Fox et al., 1991) and 
recombinant human BM-40/osteonectin (Nischt et al,, 1991) were obtained 
from stably transfected human cell clones. Human plasma yon Willebrand 
factor was a kind gift of Dr. N. Heimburger (Behringwerke AG, Germany). 
Vitronectin was  prepared  from  human plasma after  urea  activation  by 
heparin-affinity chromatography (Yatohogo et at.,  1988). 
Human  collagens I,  III,  V,  and  VI were solubilized by pepsin from 
placenta and purified following standard protocols (Miller and  Rhodes, 
1982;  Odermatt  et  al.,  1983).  Collagen  II  was  obtained  from  pepsin 
digested bovine hyaline cartilage (Miller and Rhodes,  1982).  Truncated 
procollagens pNI and pNIII, possessing only the amino propeptide, and col- 
lagens  I  and  III  were  obtained  by  neutral  salt  extraction  from  der- 
matosparactic sheep skin and fetal bovine skin and purified by NaCI precipi- 
tation and DEAE cellulose chromatography (Timpl et al., 1975). Collagen 
IV was solubilized from the EHS tumor by partial reduction (Yurchenco and 
Furthmayr,  1984).  The NH2-terminal globule (N9-N2;  Chu et al.,  1990) 
of the human collagen VI t~3(VI) chain was prepared by the recombinant 
methods used previously (Fox et al.,  1991) and appeared after purification 
as a single 150-kD band (Specks et al., 1992).  Reduction and alkylation of 
pepsin-solubilized collagen VI was performed under nondenaturing condi- 
tions (Odermatt et al.,  1983). 
Heparan sulphate (36 kD) was obtained from the proteoglycan referred 
to above by alkaline degradation (Paulsson et al., 1987a). Heparin (,',,15 kD) 
and chondroitin sulphate were commercial products. 
Proteolytic Digestions and Separation of  Fragments 
NC3 fragment was prepared by digesting collagen XIV with bacterial col- 
tagenase (CLSPA; Worthington, Freehold, NJ), at an enzyme-substrate ra- 
tio 1:100 for 1 h at 37~  in 0.2 M ammonium hydrogen carbonate contain- 
ing 10 mM N-ethylmaleimide and 0.3 mM PMSE The digested material 
was mixed with an equal volume of 100 mM Tris-HC1,  20 mM EDTA, pH 
8.0 then applied to a HiTrap Heparin column (5 ml; Pharmacia Biosystems 
GmbH) equilibrated with 50 mM Tris-HCl,  10 mM EDTA, pH 8.0. Un- 
bound material was lyophilized and used to obtain amino acid sequences 
(see below). Bound material was eluted with a 0-0.5 M NaCI gradient (35 
ml). The major eluted peak was concentrated, dialyzed against 0.2 M am- 
monium hydrogen carbonate, and stored at  -20~ 
The nonbinding lyophilized collagenase fragments were dissolved in dis- 
tilled water and acidified with formic acid. The material was injected onto 
a Nucleosil 300-10 C18 column (Macherey-Nagel GmbH & Co. KG, Dfi- 
ten, Germany) equilibrated with 0.1% trifluoroacetic acid and bound mate- 
rial was eluted with a 0-63 % acetonitrile gradient (70 ml). 
Collagen XIV dissolved in 0.5 M acetic acid was digested with pepsin 
(eazyme/substrate ratio,  1:100) for 20 h at 15~  and the reaction stopped 
by neutralization. After reduction with 2-mereaptoethanol, fragments were 
separated by electrophoresis. 
To obtain tryptic fragments, collagen XIV was digested with TPCK- 
treated trypsin (Worthington) (enzyme/substrate ratio,  1:100)  for 7  h  at 
37~  The reaction was stopped by adding an equal volume of 100 mM Tris- 
HCI, 20 mM EDTA, pH 8, then PMSF was added to 0.3 mM. The mixture 
was passed over a HiTrap Heparin column (5 ml) and bound material was 
eluted with a 0-0.6 M NaCI gradient (50 ml). Fragments from an aliquot 
of  the unbound fraction were applied to a FPLC MonoQ column, and hound 
material was eluted with a 0-0.6 M NaCI gradient (35 ml). A major peak 
eluting at 0.4 M NaC1 was mixed with an equal volume of g M urea and 
digested with TPCK-treated trypsin (enzyme/substrate ratio,  1:100) over- 
night at 37~  Digested material was lyophilized, redissolved in distilled 
water, and acidified with formic acid; then fragments were separated on a 
Nucleosi1300-10 C18 column as described above for collagenase fragments. 
Analytical Methods and Rotary Shadowing 
Amino acid compositions were determined after hydrolysis with 6 M HCI 
(16 h, 110~  on a LC 5001 analyzer (Biotronik, Malntal, Germany). PAGE 
The Journal of Cell Biology,  Volume 120, 1993  558 on 3-10 % gradient gels (unless otherwise indicated) was carried out in SDS. 
Samples were analyzed nonreduced or after reduction with 2-mercapto- 
ethanol. Gels were calibrated with globular proteins and the laminin-nido- 
gen complex or with CNBr peptides of collagen cd(I) chain. Edman degra- 
dation was carried out in gas phase sequencer models 470A and 473  A 
(Applied Biosystems, Foster City, CA) following the manufacturer's instruc- 
tions. Samples (0.1-1 nmol) were either chromatographically purified or 
were electrophoresed, electroblotted onto an Immobilon-P membrane (Mil- 
lipore GmbH, Eschborn, Germany) in 10 mM Na2B407, and stained with 
Coomassie Brilliant Blue R250, after which individual bands were excised 
and  subjected  to  Edman  degradation.  Protein  shapes  were  visualized 
by electron microscopy after rotary  shadowing (Paulsson et al.,  1987a, 
1987b),  using samples dissolved either in 0.2 M  NH4HCO3  or in 0.1  M 
acetic acid. 
Immunological Methods 
Immunization of rabbits and radioimmunobinding and radioimmunoinhibi- 
tion assays followed standard protocols (Timpl,  1982).  ELISAs were car- 
ried out as described for the binding assays. Quantitative radioimmunoinhi- 
bition assays were established for collagen XIV (IC50 ~  25 ng/ml), plasma 
fibronectin (IC50 ~  8 ng/ml), and human placental laminin (IC50 ,,o 200 
ng/ml) using specific antisera. The two isoforms of laminin (see above) were 
of equal inhibitory capacity.  For affinity purification (Timpl, 1982) of anti- 
bodies from a rabbit antiserum to collagen XIV, the serum was first passed 
over laminin and fibronectin immunoadsorbents and then over a collagen 
XIV immunoadsorbent. Antibodies displaced from the last column were 
then used in some of the studies. Rabbit antisera against the bovine collagen 
XII-like proteins TL-A and TL-B (Lunstrum et al.,  1991a;  Keene et al., 
1991) were a kind gift of Dr. G. Lunstrum. mAbs IST-3, IST-4,  and BC-1, 
specific for different fibronectin domains (Carnemolla et al.,  1989),  were 
kindly supplied by Dr.  L. Zardi. Monoclonal antifibronectin antibody 3E3 
was obtained from a commercial source (Biomol Feinchemikalien GmbH, 
Hamburg, Germany). 
Protein Binding and Cell Adhesion Assays 
Protein-protein interactions were analyzed with collagen XIV used as im- 
mobilized or soluble ligand following a previous protocol (Aumailley et al., 
1989a)  with some modifications. Wells were coated with first ligand (5 
/xg/ml, 50/~l/well) and then blocked with 2% milk powder dissolved in 0.05 
M  Tris-HC1,  pH 7.2, 0.15 M NaC1 (TBS). All further steps were carried 
out in 2% milk powder in TBS and washes between steps were with TBS, 
0.04%  Tween-20. Incubation with soluble ligand (0.%50 ttg/ml) followed 
by detection of this ligand with specific antiserum and anti-IgG conjugated 
to peroxidase was as previously described (Aumailley et al., 1989a).  Bound 
peroxidase  was  visualized  with  5-aminosalicylic  acid  (1  mg/ml)  and 
0.0045%  H~O2 dissolved in 0.02  M  Na2HPO4  adjusted to pH  6.8  with 
citric acid. Negative control values, from wells in which the soluble ligand 
was omitted, were subtracted from the binding data. For inhibition assays, 
soluble ligands were incubated with inhibitors (0.03-30/zg/ml) for 6 h at 
4~  before being added to the immobilized ligand. 
Cell adhesion to coated 96 well plates followed a colorimetric detection 
assay used previously (Aumailley et al., 1989b).  Dose response profiles for 
collagen XIV, plasma fibronectin, and human placental laminin were deter- 
mined by using the proteins at various coating concentrations (0.4-40/~g/ 
ml, 100/zl/well). Most of the established cell lines used here have been pre- 
viously described (Aumailley et al.,  1989b).  Serum-free culture medium 
was taken over a period of 24 h for radioimmunoassays. 
Results 
Purification and Structural Characterization of 
Collagen XI  V and Fibronectin  from Placenta 
Neutral salt extracts that did not contain any detergent or 
other denaturing agents were prepared from washed human 
placentae.  Extracts prepared from a  single placenta  con- 
tained 80-150 mg collagen XIV,  15-35 mg fibronectin, and 
11 mg laminin as shown by specific radioimmunoassays at 
later stages of these investigations. 5 M NaC1 precipitation 
gave rise to enrichment in these three proteins, which were 
partially separated from each other by affinity chromatogra- 
phy on a heparin column (Fig.  1). Most of the laminin did 
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Figure  1.  Separation  of  human  placental  proteins  by  heparin- 
Sepharose.  The  column  was  eluted  with  a  linear  NaC1  gradient 
(dashed  line).  The  distribution  of  collagen  XIV,  laminin,  and 
fibronectin in eluted pools 1-I2, H3,  and H4 (horizontal bars) and 
in the unbound fraction H1 (not shown) was determined by radioim- 
munoassay and is shown in the table at the top of the figure. 
not bind to heparin. Elution of the column with a NaC1 gra- 
dient revealed a  broad peak in which most of fibronectin 
eluted with the collagen XIV.  Separation of collagen XIV 
from fibronectin was achieved by FPLC on MonoQ (Fig. 2), 
and a final step on a Superose 6 column efficiently removed 
contaminations of proteolytic activity that would partially 
cleave collagen XIV at 37~  The final yield of collagen XIV 
was ~3-4 mg with a low content (w/w) of laminin (3-5%) 
and fibronectin (1%) as determined by radioimmunoassays. 
Purified collagen XIV remained near the top of the gra- 
dient electrophoresis gel when nonreduced and after reduc- 
tion resolved into major bands of 340 kD and 210 kD with 
a fainter band at 195 kD (Fig. 3 a and b). The 340-kD band 
Separation of  Collagen XIV and  Fibtonectin  by MonaQ 
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Figure 2.  MonoQ separation of fibronectin and collagen XIV. The 
positions of fibronectin and collagen XIV (horizontal bars) were 
determined by electrophoresis. Low levels of laminin contamina- 
tion eluted with the fibronectin. The column was equilibrated in a 
buffer containing 0.1  M  NaC1 and eluted with a  linear NaC1 gra- 
dient (dashed line). 
Brown et al. Human Placental Collagen XIV  559 Figure 3. SDS-gel electrophoresis of purified collagen XIV, fragment NC3 and fibronectin (a and b), of further proteolytic fragments (d) 
and immunoblotting with afffinity-purified  antibody against collagen XIV (c). Lanes in a and b were loaded with purified collagen XIV 
(lane 1 ), fragment NC3 (lane 2), and placental fibronectin (lane 3). Samples were either nonreduced (-ME) or reduced with 2-mercap- 
toethanol  (+ME). Immunoblotting (c) was done with an affinity-purified antibody to collagen XIV. The samples were reduced collagen 
XIV (lane 4) or crude placental extract (lane 5). Samples in a-c were analyzed on 3-10% gradient gels and the runs calibrated with reduced 
globular proteins  (molecular masses given on the left side in kD), larninin A (400 kD) and B (220 kD) chains,  and nidogen (150 kD). 
8-18%  gradient gels were used in d and loaded with a reduced trypsin digest (lane 6) and a reduced pepsin digest (lane 7) of collagen 
XIV. Calibration was either with globular proteins (lane 6) or with CNBr peptides of collagen cd(I) chain (lane 7). The positions of frag- 
ments P1 and P2 (lane  7) are indicated by arrowheads. 
was not observed in all gels even from the same collagen XIV 
preparation and was never seen with reduced and alkylated 
collagen XIV, and was therefore considered to be an artefact 
of incomplete reduction. Amino acid analysis demonstrated 
the presence of significant amounts of 4-hydroxyproline and 
hydroxylysine (Table I) which, however, were low enough to 
Table I. Amino Acid Composition of Human Collagen 
XIV, its NC3 Domain, and Human Placental Fibronectin 
Collagen XIV  NC3  Fibronectin 
(residues~I,000) 
4-Hydroxyproline  24  0  0 
Proline  68  52  72 
Aspartic acid  92  97  95 
Threonine  78  73  98 
Serine  74  87  75 
Glutamic acid  119  114  119 
Glycine  114  117  182 
Alanine  57  58  45 
Half cystine  5  5  5 
Valine  67  70  68 
Methionine  7  24  3 
Isoleucine  46  49  38 
Leucine  72  79  52 
Tyrosine  26  20  19 
Phenylalanine  33  37  19 
Histidine  28  33  33 
Hydroxylysine  4  0  0 
Lysine  41  43  28 
Arginine  45  44  49 
indicate the presence of large noncollagenous regions. Elec- 
tron microscope images after rotary shadowing of the pro- 
tein at neutral pH showed cross-shaped particles (Fig. 4 A 
and B). They consisted of thick rodlike segments (~50 nm) 
in  a  three-armed arrangement which  were connected to a 
thin, 70-nm-long strand. This thin strand frequently showed 
a kink ~30 nm away from its free end. The thick rods col- 
lapsed into compact globules when collagen XIV was dis- 
solved in dilute acetic acid (Fig. 4 C). The same change has 
been reported  for the  collagen XII-like component TL-B 
from bovine skin (Lunstrum et al.,  1991a),  which has re- 
cently been identified as collagen XIV by sequence analysis 
(Lunstrum et al.,  1992). Furthermore, an antiserum against 
TL-B reacted much more strongly in ELISA with the placen- 
tal collagen XIV than an antiserum against TL-A, indicating 
that TL-B and placental collagen XIV are closely related. 
Brief digestion  (1  h)  of collagen  XIV by bacterial  col- 
lagenase reduced the apparent molecular mass of the constit- 
uent chains to a doublet of 180/165 kD (Fig. 3 a, lane 2) indi- 
cating that the triple helical domains contribute ~15 % to the 
total  mass.  Electrophoresis  of  this  coUagenase-resistant 
fragment under nonreducing  conditions  (Fig.  3  b,  lane 2) 
gave predominantly a band of slightly faster mobility than 
the disulphide-linked intact collagen XIV molecule (Fig.  3 
b,  lane/),  indicating  that the fragment is  still disulphide- 
linked. By analogy with the closely related molecule colla- 
gen XII, this collagenase-resistant fragment is probably the 
large,  NH2-terminal NC3  domain.  This NC3  domain was 
purified by heparin-affinity chromatography and showed an 
amino  acid  composition with  negligible  levels of hydrox- 
yproline  (Table  I).  Electron  microscopy of NC3  demon- 
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purified component showed a broad band at ,o220 kD in both 
reduced and nonreduced gels (Fig.  3 a  and b).  The amino 
acid composition was different to that of collagen XIV and 
its  NC3  domain  (Table  I).  The  nature  of the  placental 
fibronectin  was  examined  in  ELISA with  several  specific 
mAbs. They detected the extra type III domain ED-A (mAb 
IST-3) but not ED-B (mAb IST-4), and binding was also ob- 
served for mAbs BC-1 and 3E3, which bind to epitopes com- 
mon to cellular and plasma fibronectin (Carnemolla et al., 
1989). Only BC-1 and 3E3 reacted with plasma fibronectin, 
demonstrating that the placenta-derived fibronectin contains 
a  distinct proportion of cellular  fibronectin possessing do- 
main ED-A (Hynes,  1990). 
Figure 4, Rotary shadowing images of  collagen XIV shown as a rep- 
resentative  field (A) and as selected  particles (B and C). Samples 
in A and B were dissolved in 0.2 M ammonium hydrogen carbonate 
pH 7.9 and in C in 0.1 M acetic acid. Bar,  50 nm. 
strated the three-armed structure of the rods which lacked, 
however, the thin 70-nm strand  (not shown). 
Because tissue forms of fibronectin are not readily avail- 
able (Hynes,  1990),  we also purified placental fibronectin 
Partial Sequence Analysis of Collagen XIV 
To confirm the identity of  the placental collagen XIV, limited 
NH:-terminal sequencing was carded out on selected pep- 
tides. We started by a selective approach for the triple helical 
domains Coil and Co!2. Pepsin digestion of collagen XIV, 
which should release Coil and Co12 in intact form, showed 
an electrophoresis pattern with several bands with fast mo- 
bilities of <,x, 30 kD when compared to collagen I peptides 
(Fig. 3 d). The same NH:-terminal sequence was found for 
fragments P1 (28 kD) and P2 (13 kD) and came from a junc- 
tion region between a noncollagenous and a collagenous do- 
main. When compared to the known chick collagen XIV se- 
quences (Gordon et al.,  1991; Trueb and Trueb,  1992), the 
peptide  sequence  showed  slightly  higher  identity  (8/14 
residues) with the junction between domains NC3 and Co12 
than with the sequence at the junction between NC2 and Coil 
(7/14 residues).  In support of a localization of this sequence 
to the NC3/Co12 junction was the interpretation of the data 
to mean that P2 corresponds to domain Co12 and P1  to an 
uncleaved combination of domains Co11-Co12.  The peptide 
sequence showed a similar level of identity to chick collagen 
XII in this region (Table II). The remaining bands gave het- 
Table II. Partial Amino Acid Sequences of  Human Collagen XIV  Fragments and Their Correlation to Chick Collagen 
XII and XIV Sequences 
Human collagen XIV sequence 
Match to 
Chick collagen Xll 
Chick collagen XIV 
Positions  Identity (%)  Identity (%) 
Pl, P2  VALGPAGPPGGPGL  2748-2761  57  57 
Cl  GPPGGPGLRGPXGQ  --  -  - 
C2  GPQGIPGGVGSPGRDGSP  2837-2854  50  - 
C3  GPPGHLGVP  3028-3036  56  67 
o  o  ￿9 
C4  GTPGFPGNAGVPGTPGER  2967  -2998  *  67  76 
GLTGIXGEXGNPGVGTQ 
C5  GPSGLSIQGMP  2799-2809  64  91 
C6  GPIGIPGTPGVPGITSM  2861-2878  56  87w 
T 1  ASAXAITGPPTELITSE  1379-1395  29  -  r 
TI'  LTWDPTSR  1585-1592  38  75 
Fragments were generated by digestion with pepsin (P), bacterial collagenase (C), or trypsin (T). A dot over P indicates 4-hydroxyproline. Identity of peptide 
sequences with corresponding  published sequences of chick collagen  XII (Yamagata  et al., 1991) and chick  collagen XIV (Gordon  et al., 1991; Trueb and Trueb, 
1992) is shown. The numbering of the chick collagen XII sequence is from Yamagata et al. (1991). X, nonidentified residues. 
* A three-residue gap was introduced into the collagen XII sequence, as described in Gordon  et al. (1991), to allow alignment. 
~: This part of the chick collagen XIV sequence has not yet been published. 
w  Match for residues 4-18 of peptide C6. The chick collagen XIV sequence corresponding  to residues 1-3 is not yet known, 
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Figure 5. Elution profile of small collagenase-derived peptides of 
collagen  XIV  from  HPLC  C18  reverse  phase  column.  NH2- 
terminal sequences were determined for peptides in labeled peaks 
C1-C6 (Table II). The column was in 0.1% trifluoroacetic acid and 
was eluted with a linear acetonitrile gradient (dashed line). 
erogeneous sequences, indicating fuzzy ends generated by 
pepsin cleavage. 
Further sequence data were generated from small collage- 
nase-derived collagen XIV peptides that did not bind to a 
heparin column.  Reverse-phase chromatography showed a 
profile of limited complexity (Fig. 5), and six major peaks, 
C1 to C6, gave clearly identifiable sequences (Table II). Pep- 
tides C5 and C6 matched the Co12 region of chick collagen 
XIV and peptides C3 and C4 matched its Coil region. These 
peptides, and in addition peptide C2, also matched the corre- 
sponding chick collagen XII sequences, although with lower 
levels of identity (Table II). Peptide C1 showed no strong cor- 
respondence to any collagen XII or collagen XIV sequence 
and may originate from a less conserved region of collagen 
XIV. An overall identity of 59% (59/100 residues) was seen 
between peptides P1/P2 and C2-C6 and the corresponding 
chick collagen XII sequences.  Only incomplete sequence 
data are available from the Coil and Co12 domains of bovine 
(Dublet and van der Rest,  1991) and chick (Gordon et al., 
1991; Trueb and Trueb, 1992) collagen XIV, but of the se- 
quences that could be matched, 90%  identity (43/48 resi- 
dues) was seen with bovine collagen XIV and 76% identity 
(44/57 residues) with chick collagen XIV.  Thus, the data 
clearly show that our placental collagen possesses the do- 
mains Coil and Co12 of collagen XIV. 
Sequences of the  NH2-terminal domain  NC3  were ob- 
tained from large tryptic fragments. A trypsin digest of  colla- 
gen XIV produced a major 80-kD band (fragment T1; Fig. 
3  d)  together with  several minor bands  in  the  range  of 
20-140 kD. Passage over a heparin affinity column produced 
only little binding of a few smaller fragments that did not 
give  clear  NH~-terminal  sequences.  The  nonbound  frag- 
ment T1 was further purified on a MonoQ column. An inter- 
nal fragment Tr was then generated by a  second cleavage 
with trypsin in 4 M urea and was purified by chromatography 
on  a  C18  reverse  phase  column.  The  NH2-terminal  se- 
quences of collagen XIV fragments T1 and Tr were identical 
to cDNA-predicted sequences of human undulin (Just et al., 
1991) corresponding to positions 160-176 and 366-373 in 
clone Unl. Tr could also be matched to a sequence in the 
NC3  domain  of chick collagen  XIV  (Trueb  and  Trueb, 
1992), and the two sequences showed some identity with two 
different fibronectin type III motif sequences within the NC3 
domain of chick collagen XU (Table II). 
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Figure 6. Characterization of antibodies against collagen XIV by radioimmunobinding (a) and inhibition (b) assays. Binding (a) was deter- 
mined with a rabbit antiserum before (closed symbols) and after (open symbols) affinity-purification  on a collagen XIV immunoadsorbent. 
Binding curves are shown for 12SI-labeled  collagen XIV (o, e) and plasma fibronectin (zx, A). In the inhibition assay (b), a fixed dilution 
of antiserum to collagen XIV was incubated with nonlabeled inhibitors before the addition of '2SI-labeled collagen XIV. Inhibitors used 
were collagen XIV (e), reduced and alkylated collagen XIV (o), fragment NC3 of collagen XIV (A), pepsin digest of collagen XIV (r,), 
plasma fibronectin (=), von Willebrand factor (t2), and vitronectin (v). The globular domain N2-N9 of collagen VI or3 chain was also 
not active as an inhibitor (not shown). 
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1issue Studies 
A rabbit antiserum against human collagen XIV showed a 
strong binding in radioimmunoassays (Fig. 6 a) and ELISA 
to collagen XIV, a moderate to strong binding to fibronectin, 
and weaker reactions with placental laminin and collagen IV. 
After affinity purification, the antibodies displaced from a 
collagen XIV column (see Materials and Methods) retained 
a strong reaction with collagen XIV (Fig. 6 a) but showed 
negligible or no binding for the other proteins.  Specificity 
was  also  demonstrated  by  radioimmunoinhibition assays 
(Fig. 6 b). Collagen XIV was strongly inhibitory with IC5o 
20 ng/ml,  whereas >100-fold higher concentrations of 
placental laminin,  flbronectin, von Willebrand factor, vi- 
tronectin,  and NH2-terminal globular domain of collagen 
cr  chain had no significant effect. Studies with the pu- 
rified NC3 domain showed an inhibition profile similar to 
that of collagen XIV, indicating that NC3 contributes most 
of the immunogenic epitopes. Reduced and alkylated colla- 
gen XIV also produced almost complete inhibition, indicat- 
ing that the epitopes are not dependent on disulphide bonds. 
Pepsin digestion, however, caused a considerable loss in in- 
hibitory capacity (Fig.  6 b). 
Immunoblotting of reduced collagen XIV with the affinity- 
purified antibody showed a distinct reaction with the 210/ 
195-kD  doublet band (Fig.  3 c)  and in some experiments 
with the intermittently observed 340-kD  band.  The same 
blotting patterns were observed with the crude placental ex- 
tract,  demonstrating the lack of substantial amounts of a 
larger  variant of collagen XIV  (Fig.  3  c).  The  radioim- 
munoinhibition assay was used to study various biological 
fluids. Human normal sera from eight adult donors lacked 
any  significant  amounts  of  cross-reacting  antigen  (<20 
ng/ml). The same negative result (<50 ng/ml) was found for 
serum-free culture medium from seven established human 
tumor cell lines (HT1080,  HBL-100,  A375, SAOS-2, A431, 
SCII, and SV40Wi26).  An exception were rhabdomyosar- 
coma RD cells that secreted during a  24-h period  ,~240 
ng/ml collagen XIV. 
Cell Adhesion Activity of Collagen XI V 
Both collagen XII (Yamagata et al., 1991) and collagen XIV 
(Gordon et al.,  1991) possess  a  potentially cell-adhesive 
RGD sequence located at the COOH-terminal end of the 
Co12 domain. To examine cell attachment activity, we com- 
pared the dose-response profile of collagen XIV with those 
of human placental laminin and fibronectin in cell attach- 
ment assays (Fig. 6). The established cell lines used were HT 
1080  (human fibrosarcoma),  HBL-100 (human mammary 
epithelium), A431 (human epidermoid), A375 (human mel- 
anoma),  SCII  (human  epidermal  carcinoma),  Rugli  (rat 
glioma), RN22  (rat schwannoma), F9 (mouse teratocarci- 
noma), and B16F10 (mouse melanoma).  They all showed 
strong adherence to laminin and fibronectin with plateau 
values in the range of 1.1-1.8 (OD units) and coating concen- 
trations required for half maximal color yields of 0.4-0.8 
/~g/ml for laminin and of 2-5/~g/ml for fibronectin. Six of 
the cell lines did not attach at all to collagen XIV. Only HT 
1080 (Fig. 7) and Rugli cells showed some weak adhesion 
to collagen XIV but at high coating concentrations of 40 
#g/ml. Thus, the activity might be entirely attributable to the 
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Figure 7. Dose-response  profiles  of liT 1080 cell attachment to var- 
ious substrates. Wells were coated with placental laminin (e), 
fibronectin (I),  or collagen XIV  (*).  Relative numbers of at- 
tached cells were determined by a colorimetric assay. 
laminin contamination (~3%) in collagen XIV. Some low 
adhesion activity (0.50D units), but at 3 #g/ml, was found 
for B16F10 cells. 
Binding Properties of Collagen XIV  for Other 
Extracellular Matrix Proteins 
Because collagen XIV shows strong affinity for heparin (Fig. 
1), we decided to study its interaction with a large heparan 
sulphate proteoglycan known to be produced by EHS tumor 
cells (Paulsson et al., 1987a) as well as by fibroblasts (Here- 
mans et al., 1989). Immobilized proteoglycan showed a dis- 
tinct reaction with soluble collagen XIV, with half maximal 
binding at '~10 #g/ml (Fig. 8 a). A similar binding profile 
was also observed for soluble proteoglycan and immobilized 
collagen XIV.  The binding could be inhibited by heparin 
(IC50 =  0.1 /~g/ml) and heparan sulphate (IC50 =  8 #g/ml) 
but not by chondroitin sulphate (Fig. 8 b) up to a concentra- 
tion of 500/xg/ml. This indicates a specific interaction which 
is likely to be mediated by the heparan sulphate side chains 
of the proteoglycan. The NC3 fragment of collagen XIV and 
reduced and alkylated collagen XIV did not bind to the pro- 
teoglycan. 
A large variety of  other extracellular matrix or plasma pro- 
teins were inactive ligands for soluble collagen XIV (up to 
a concentration of 50 #g/ml) with an example illustrated in 
Fig. 8 a. They included pepsin-solubilized human collagens 
I, III, and V and bovine collagen II, EHS tumor collagen IV, 
neutral salt-soluble collagens I and III,  and the truncated 
procollagens pNI and pNIII. Further inactive ligands were 
placental  laminin,  EHS  tumor laminin-nidogen complex, 
nidogen, BM-40/osteonectin, plasma and placenta fibronec- 
tin,  vitronectin,  von  Willebrand  factor,  and  the  NH2- 
terminal globular domain of collagen ~3 (VI) chain. These 
potential interactions also remained negative when examined 
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Figure 8. Interaction of human collagen XIV with extraceUular matrix components. (a) Binding of soluble collagen XIV to immobilized 
heparan sulphate proteoglycan (o), collagen VI (e), and vitronectin ([~) was determined by an ELISA procedure. (b) Inhibition of binding 
of collagen XIV to heparan sulphate proteoglycan. Soluble collagen XIV was incubated with heparin (A), heparan sulphate (.,), or chon- 
droitin sulphate (zx) before being added to immobilized proteoglycan. Results are expressed as percent of binding seen in the absence of 
inhibitors. 
with immobilized collagen XIV,  although this could not be 
studied with soluble collagens I, II, ILL[,  and V due to the lack 
of sufficiently strong or specific antisera for these ligands. 
Collagen XIV did, however, bind to pepsin-solubilized hu- 
man collagen VI, both when collagen XIV and when colla- 
gen VI was used as the immobilized ligand (Fig. 8 a). This 
interaction was not shared by the NC3 fragment of collagen 
XIV.  Partial reduction of collagen VI or heat denaturation 
(20 min, 50~  which unfolds the triple helix (Odermatt et 
al.,  1983),  substantially reduced binding activity. 
Discussion 
We have purified a large disulphide-linked protein with the 
characteristic  properties  of  collagen  XIV  from  human 
placental neutral salt extracts. Electron microscopy showed 
a four-armed structure with three thick rods corresponding 
to a large globular domain NC3 originally identified in colla- 
gen XII (Dublet et al.,  1989). This domain is connected to 
a 70-nm-long thin thread that is sensitive to bacterial col- 
lagenase, a treatment that also removes all 4-hydroxyproline 
and  hydrolysine residues.  This  indicates  that  the  70-nm 
thread corresponds to the collagenous region of the mole- 
cule. The homology of this region with domains Coil and 
Co12 of bovine and chick collagen XIV (Dublet and van der 
Rest, 1991; Gordon et al., 1991; Trueb and Trueb, 1992) was 
shown directly by determining 116 of its sequence positions. 
Because the sequences were closer to the collagen XIV than 
the collagen XII sequence of chick, there is no doubt about 
the identification of the human placental protein. Further- 
more, several lines of evidence rule out significant contami- 
nation of the preparation with human collagen XII.  First, 
virtually all of the human collagen XIV molecules in the 
preparation exhibited a change in shape at acidic pH similar 
to that described for the collagen XII-like TL-B from fetal 
bovine skin (Lunstrum et al.,  1991a).  TL-B was  recently 
identified as collagen XIV by sequence analysis (Lunstrum 
et al.,  1992). Such a change in shape is not seen with TL-A 
(Lunstrum et al.,  1991a),  which represents bovine collagen 
XII (Lunstrum et al.,  1992). Second, the NC3 domains of 
bovine collagens XII and XIV could be clearly separated 
from one another on an FPLC MonoQ column,  with no 
cross-contamination detectable by mAbs specific for the two 
molecules (Lunstrum et al., 1991a). Because the human col- 
lagen XIV was purified on MonoQ with similar buffer condi- 
tions and eluted at a similar NaC1 concentration (~0.4 M) 
to bovine collagen XIV, it is likely that the human collagens 
behave similarly to their bovine counterparts and would be 
separated by this purification step if collagen XII were pres- 
ent.  Third,  none of the human  collagen XIV peptide se- 
quences showed higher homology with collagen XII than 
with collagen XIV. 
Two more sequences were generated from the NC3 do- 
main of human collagen XIV.  One of these showed a high 
level of identity with a chick collagen XIV NC3 sequence 
(Trueb and Trueb,  1992), and both showed partial identity 
to segments within fibronectin type III repeats of chick calla- 
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were identical to cDNA-derived sequences of  human undulin 
(Just et al., 1991). Undulin was recently described as a non- 
collagenous protein lacking any 4-hydroxyproline and with 
a three-armed shape (Schuppan et al., 1990). Because com- 
plete sequence identity of  24 residues is higher than expected 
by chance for two related proteins, this indicates that a sub- 
stantial portion of the sequences of human undulin and the 
NC3 domain of collagen XIV are identical. Indeed, Trueb 
and Trueb (1992) have recently shown that the amino acid 
sequence from the NC3  domain of chicken collagen XIV 
shows 71% identity with the sequence of human undulin and 
concluded that collagen XlV is a variant of undulin. The se- 
quences reported here confirm this conclusion and provide 
further evidence that undulin and collagen XIV are probably 
products  of the  same  gene,  the  sequence differences ob- 
served by Trueb and Trueb being due to species variation. 
We also isolated a tissue form of fibronectin from placenta, 
characterized by the presence of the extra type HI domain 
ED-A. Because the molecular mass (220 kD) did not change 
after reduction, this fibronectin has apparently lost a small 
COOH-terminal disulphide-bridging region. This may occur 
for example by cleavage with plasmin (Jilek and H6rmann, 
1977). Whether this fibronectin fragment is deposited in tis- 
sues in this form or is an artefact of extraction and purifica- 
tion is unknown. 
Specific antibodies against collagen XIV were generated 
by affinity purification. These failed to demonstrate larger 
forms of collagen XIV than described here (,,~210-kD  poly- 
peptides) from the placenta extracts.  A  large form (•340 
kD)  has been predicted for collagen XII from cDNA  se- 
quencing (Yamagata et al.,  1991) and shown in preliminary 
studies to exist in cell culture and cartilage (Lunstrum et al., 
1992; Watt et al.,  1992). The 340-kD band that was some- 
times observed in our studies is unlikely to represent a larger 
intact form of collagen XIV because it was unstable in the 
presence of 2-mercaptoethanol. Radioimmunoinhibition as- 
says demonstrated negligible secretion of collagen XIV for 
several human tumor cell lines except for a rhabdomyosar- 
coma.  Considering the widespread occurrence of collagen 
XIV  (TL-B)  in  tissues  as  revealed  by  immunostaining 
(Keene et al.,  1991), this could indicate that only a few cul- 
tured cells maintain collagen XIV production or that cell 
transformation decreases expression.  The serum levels of 
collagen XIV did not exceed those of other extracellular ma- 
trix proteins (Risteli and Risteli, 1987), indicating a firm an- 
chorage of this protein to the extracellular matrix. 
Such anchorage was demonstrated by the necessity to in- 
crease the ionic strength above physiological levels to ~1 M 
NaC1 for the extraction of substantial amounts of collagen 
XIV  from  placenta  (Brown  et  al.,  unpublished  observa- 
tions). This then led to the finding that collagen XIV has a 
distinct affinity for heparin, requiring 'x,0.4 M NaCI for dis- 
sociation. It was also shown that the NC3 domain possesses 
a binding site(s) for heparin. Binding sites for heparin have 
been assigned  to type III domains  in fibronectin (Hynes, 
1990) and to A domains in von Willebrand factor (Mohri et 
al.,  1989; Sixma et al.,  1991).  Homologs of these domains 
are also present in collagen XII (Yamagata et al.,  1991) and 
are likely to exist in collagen XIV. The precise localization 
of such binding domains has now become feasible. 
Collagen XIV also showed distinct binding to a basement 
membrane-derived  heparan  sulphate  proteoglycan.  Com- 
plex formation could be inhibited by heparin and with lower 
affinity by heparan sulphate, demonstrating that the glycos- 
aminoglycan chains and not the core protein of the proteo- 
glycan are responsible for binding.  A  similar or identical 
proteoglycan is also produced by fibroblasts (Heremans et 
al., 1989). Together with the immunolocalization of  collagen 
XIV  to  matrices  produced  by  fibroblasts  (Keene  et  al., 
1991), this indicates that binding to proteoglycan may be of 
relevance  in  situ.  A  surprising  observation  was  that  the 
heparin-binding domain NC3 did not bind to the heparan 
sulphate  proteoglycan.  This  could  indicate  that  several 
heparin-binding sites exist on collagen XIV, including within 
the triple helix, and/or that the release of NC3 produces sub- 
tle changes in conformation and affinity which may allow 
binding to the sulphate-rich heparin but not to the undersul- 
phated heparan sulphate (Pejler et al.,  1987) in agreement 
with the different affinities shown by inhibition assays (Fig. 
8 b). Preliminary studies with chymotryptic digests have in 
fact indicated that collagen XIV may possess more than one 
heparin-binding site (Brown et al., unpublished). 
The only other significant binding activity of  collagen XIV 
so  far  observed was  with  pepsin-solubilized  collagen  VI 
from human placenta. This truncated collagen VI consists 
mainly of the 100-nm-long triple helical domain and some 
small residual structures of the adjacent globular domains 
N1 and C1 (Odermatt et al.,  1983; Chu et al.,  1987,  1988). 
Immunoelectron microscopy has shown that collagens XIV 
(Keene et al.,  1991) and VI  (vonder Mark et al.,  1984; 
Bruns et al.,  1986; Keene et al.,  1988) are found in close 
vicinity to the major cross-striated collagen fibrils. Although 
collagen XII shows only limited colocalization with collagen 
VI (Keene et al.,  1991),  similar colocalization studies with 
collagen XIV have yet to be carried out. Because the NC3 
domain does not bind, it may be that the triple helix of colla- 
gen XIV associates with that of collagen VI. Both triple heli- 
cal domains,  that of collagen XIV as shown here and that 
available on the surface of collagen VI microfibrils (Furth- 
mayr et al.,  1983; Bruns,  1984; Bruns et al.,  1986), have 
about the same length (70 nm), which would allow a perfect 
match over their entire length. 
Quite a few other extracellular matrix proteins, however, 
were not active in binding assays with collagen XIV.  They 
included in particular the fibril-forming collagens I-III and 
V and the pN-collagens I and III. The latter were included in 
this study because of the immunoelectron microscopical evi- 
dence (Fleischmajer et al., 1981, 1990) for their localization 
on the surface of major collagen fibrils. Our data are differ- 
ent to those reported for undulin, which has been reported 
to bind to collagens I and III, as well as collagen VI (Just 
et al., 1991), and do not of course exclude the possibility that 
intact fibrils rather than monomeric collagens provide the 
appropriate  binding  structures  for collagen  XIV.  Several 
basement membrane proteins and other noncollagenous ex- 
tracellular matrix proteins also failed to bind collagen XIV. 
However, when studied by the same assay,  distinct interac- 
tions have been found between laminin, collagen IV, nido- 
gen,  BM-40,  proteoglycan, and  fibronectin (Aumailley et 
al., 1989a, 1993; Mayer et al., 1991, Fox et al., 1991; Nischt 
et al.,  1991), demonstrating the utility of the procedure. We 
also failed to demonstrate significant cell adhesiveness of 
collagen XIV with a panel of tumor cells that together pos- 
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actions, i.e., cd/31 to a6fll and avfl3  (e.g.,  Sonnenberg et 
al.,  1990).  Some  weak  activity  was  found,  however,  for 
B16F10 melanoma cells. This could correlate with the obser- 
vations of Yamagata et al. (1991),  who showed distinct adhe- 
sion of B16F10 cells to a synthetic RGD-peptide designed ac- 
cording to the chick collagen XII sequence.  Nevertheless, 
collagen  XIV  does  not  seem at  all  comparable  to  strong 
and widely recognized adhesion substrates  such as laminin, 
fibronectin, and collagens IV and VI. 
The group of collagens referred to as FACITs (Shaw and 
Olsen,  1991; van der Rest et al.,  1991) have been proposed 
to be associated with the major fibrillar collagens in tissues. 
While we observed no binding of collagen XIV to isolated 
fibril-forming  collagens,  the  association  could  take  place 
directly with a higher order structure  of the intact fibril or 
indirectly via a bridging molecule.  Although an immuno- 
electron microscopical study indicated that most of the colla- 
gen XIV was found in close vicinity to the major collagen 
fibrils, it was not associated with all fibrils in the preparation 
and in some instances it was localized between fibrils (Keene 
et al., 1991),  indicating that collagen XIV may bind to multi- 
ple components of the extracellular matrix. This concept is 
supported by our data,  which suggest a possible association 
of some FACITs with microfibrils and proteoglycans. 
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